Skip to main content
. Author manuscript; available in PMC: 2021 Sep 15.
Published in final edited form as: Cancer Res. 2021 Jan 20;81(6):1607–1615. doi: 10.1158/0008-5472.CAN-20-1237

Table 2:

The odds ratio and 95% confidence intervals of the PRS and lung cancer risk by decile in OncoArray and UK Biobank

PRS decile Model building (OncoArray) Validation (UK Biobank)
OR (95%CI)a P-value OR (95%CI)b P-value
0–10% 1(Referent) 1 (Referent)
10–20% 1.30 (1.15,1.46) 1.39 ×10−5 1.31 (1.02, 1.68) 3.54 ×10−2
20–30% 1.62 (1.44, 1.82) 1.34 ×10−15 1.16 (0.90, 1.50) 2.46 ×10−1
30–40% 1.58 (1.41, 1.78) 1.94 ×10−14 1.57 (1.24, 2.00) 2.07 ×10−4
40–50% 1.77 (1.57, 1.99) 3.18 ×10−21 1.67 (1.32, 2.12) 2.25 ×10−5
50–60% 2.01 (1.78, 2.26) 1.12 ×10−30 1.56 (1.23, 1.98) 2.92 ×10−4
60–70% 2.19 (1.94, 2.46) 7.91 ×10−38 1.67 (1.32, 2.13) 1.89 ×10−5
70–80% 2.38 (2.11, 2.69) 1.07 ×10−45 1.69 (1.34, 2.15) 1.27 ×10−5
80–90% 2.70 (2.39, 3.04) 4.23 ×10−58 2.00 (1.60, 2.53) 2.58 ×10−9
90–100% 3.52 (3.11, 3.98) 7.34 ×10−88 2.39 (1.92, 3.00) 1.80 ×10−14
Trend p-value 1.77 × 10−127 5.26 ×10−20
a,

adjusted for age, sex and top 5 principal components

b,

adjusted for age, sex and top 5 principal components